Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toward reprogramming cells to pluripotency.

P Collas1, C K Taranger

  • 1Institute of Basic Medical Sciences, Department of Biochemistry, University of Oslo, Norway. phillippe.collas@medisin.uio.no

Ernst Schering Research Foundation Workshop
|August 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas.

Nature communications·2021
Same author

Dedifferentiation of cells: new approaches.

Cytotherapy·2007
Same author

Dynamics of the nuclear envelope at mitosis and during apoptosis.

Cellular and molecular life sciences : CMLS·2002
Same author

CDK1-mediated phosphorylation of the RIIalpha regulatory subunit of PKA works as a molecular switch that promotes dissociation of RIIalpha from centrosomes at mitosis.

Journal of cell science·2001
Same author

Regulation of anchoring of the RIIalpha regulatory subunit of PKA to AKAP95 by threonine phosphorylation of RIIalpha: implications for chromosome dynamics at mitosis.

Journal of cell science·2001
Same author

Binding of PKA-RIIalpha to the Adenovirus E1A12S oncoprotein correlates with its nuclear translocation and an increase in PKA-dependent promoter activity.

Virology·2001
Same journal

Stem cells in reproduction and in the brain. Proceedings of a workshop. September 1-3, 2005. Kobe, Japan.

Ernst Schering Research Foundation workshop·2007
Same journal

Can cell systems biology rescue drug discovery?

Ernst Schering Research Foundation workshop·2007
Same journal

Applying a causal framework to system modeling.

Ernst Schering Research Foundation workshop·2007
Same journal

A plea for more theory in molecular biology.

Ernst Schering Research Foundation workshop·2007
Same journal

Network genomics.

Ernst Schering Research Foundation workshop·2007
Same journal

The theory of biological robustness and its implication in cancer.

Ernst Schering Research Foundation workshop·2007
See all related articles

Scientists are exploring new ways to change cell types for regenerative medicine. Non-nuclear transfer methods offer promising alternatives to therapeutic cloning for cell fate reprogramming and differentiation.

Area of Science:

  • * Regenerative Medicine
  • * Developmental Biology
  • * Cell Biology

Background:

  • * The potential for cell type conversion holds significant promise for regenerative medicine applications.
  • * Somatic cell nuclear transfer (therapeutic cloning) is one method, but faces ethical restrictions in many regions.
  • * Alternative strategies are actively being pursued to overcome these limitations.

Purpose of the Study:

  • * To review recent advancements in non-nuclear transfer-based in vitro cell reprogramming.
  • * To highlight methods that enhance cellular differentiation potential toward various lineages.
  • * To discuss the future prospects of these alternative approaches in regenerative medicine.

Main Methods:

  • * Review of current literature on in vitro cell reprogramming techniques.

Related Experiment Videos

  • * Analysis of non-nuclear transfer-based strategies for altering cell fate.
  • * Examination of methods promoting cell differentiation into diverse lineages.

    • Main Results:

    • * Several innovative in vitro approaches for cell reprogramming have emerged.
    • * These methods bypass the ethical concerns associated with therapeutic cloning.
    • * Demonstrated success in enhancing the differentiation potential of reprogrammed cells.

    Conclusions:

    • * Non-nuclear transfer methods represent a viable and ethically sound alternative for cell reprogramming.
    • * These techniques are crucial for advancing regenerative medicine.
    • * Continued research in this area is expected to yield further breakthroughs in cell-based therapies.